**Dear Editor**,

Following the recent description of transmissible plasmid-mediated colistin resistance encoded by *mcr-1* in clinical and veterinary *Escherichia coli* and *Klebsiella pneumoniae* isolates in China,^[@bib1]^ several groups have reported *mcr-1* in colistin-resistant isolates from humans and food animals across Asia^[@bib2],\ [@bib3],\ [@bib4]^ to Europe.^[@bib5],\ [@bib6],\ [@bib7],\ [@bib8]^ It is evident that *mcr-1* has disseminated globally.

We performed a prospective study in January 2016 using 306 consecutive clinical Enterobacteriaceae isolates collected from blood, urine and miscellaneous samples (swabs and pus). The species investigated were *E. coli* (*n*=166), *K. pneumoniae* (*n*=87), *Klebsiella oxytoca* (*n*=4), *Enterobacter* spp. (*n*=22), *Proteus* spp. (*n*=10), *Citrobacter* spp. (*n*=9), *Morganella morganii* (*n*=5), *Providencia rettgeri* (*n*=1), *Salmonella enteritidis* (*n*=1) and *Serratia marcescens* (*n*=1). Isolates were PCR-screened for *mcr-1*^[@bib1]^ without prior knowledge of their antibiograms or colistin-resistance status. Three of these isolates (two *E. coli* and one *K. pneumoniae*) were *mcr-1* positive, with their full-length *mcr-1* gene matching the nucleotide identity of the first-described isolate exactly.^[@bib1]^ Multilocus sequence typing (MLST) was performed (<http://bigsdb.web.pasteur.fr/index.html>). There was no evidence of nosocomial transmission, as the two *E. coli* isolates were of different sequence types (STs; [Table 1](#tbl1){ref-type="table"}).

The isolates were urinary specimens ([Table 1](#tbl1){ref-type="table"}). Our detection rate was estimated to be 0.98% (95% confidence interval of 0.3%--2.8%, Wilson score interval). This was very close to 1% *mcr-1* prevalence in China.^[@bib1]^ Sensitivity testing was performed via E-test for polymyxin B and colistin and with the Vitek2 GNR257 card for all other antimicrobials. Phenotypically, the isolates were resistant to polymyxin B (minimum inhibitory concentration (MIC) 4 mg/L--24 mg/L) and colistin (MIC 4 mg/L--8 mg/L) but were sensitive to carbapenems. There was a variable sensitivity to third-generation cephalosporins and piperacillin-tazobactam ([Table 1](#tbl1){ref-type="table"}). PCR screening for carbapenemases (*K. pneumoniae* carbapenemase (KPC), metallo-β-lactamases (New Delhi Metallo-β-lactamase (NDM), verona integron-encoded metallo-β-lactamase, imipenemase), class D carbapenemases (oxacillinase (OXA)-23, OXA-48-like)) and broad- and extended-spectrum β-lactamases (BSBL and ESBLs) was performed.^[@bib9]^ Only narrow-spectrum β-lactamase (TEM)-1 BSBL was detected in the *E. coli* isolates ([Table 1](#tbl1){ref-type="table"}). This was noteworthy because *mcr-1*-positive isolates have been found to be associated with cefotaximase (CTX)-M-like ESBLs.^[@bib4],\ [@bib5],\ [@bib6]^ Furthermore, in our isolates, carbapenemase genes were not carried with *mcr-1*, which contrasts growing reports in which *mcr-1* has been found together with *bla*~KPC-2~ and *bla*~NDM~ carbapenemase genes^[@bib7],\ [@bib8]^ and results in colistin-resistant isolates that are also carbapenem resistant.^[@bib7],\ [@bib8]^ Using liquid-mating assays, *mcr-1* was transferable to an *E. coli* recipient, J53, in all the clinical donor isolates. Transconjugants were selected on Luria Bertani agar containing 50 mg/L of sodium azide and 0.5 mg/L of colistin. All of the transconjugants were phenotypically resistant to colistin and polymyxin B. TEM-1 also transferred in two transconjugants ([Table 1](#tbl1){ref-type="table"}). PCR replicon typing^[@bib10]^ indicated that the transconjugants of NM2 and NM12 could not be typed, while transconjugant NM4 carried IncF and IncI1. The genetic environment of *mcr-1* is variable and is not always associated with an upstream ISApl*1*.^[@bib7]^ Here PCR mapping and sequencing based on the initial genetic environment^[@bib1]^ showed that one isolate did not have a flanking ISApI*1* ([Table 1](#tbl1){ref-type="table"}). This suggests that the dissemination of *mcr-1* is likely facilitated by a diverse range of mobile genetic elements. We plan to commence full-genome sequencing in the near future to characterize the plasmids and mobile elements in detail. Because Singapore has limited farming and agricultural activity, *mcr-1* is less likely to be acquired through contact with local livestock; although not yet conclusively proven, it appears that imported meat products and vegetables are more likely sources of *mcr-1*.^[@bib11],\ [@bib12],\ [@bib13]^

We thank the team of curators of the Pasteur Institute MLST and whole genome MLST databases for curating the data and making it publicly available at <http://bigsdb.web.pasteur.fr/>.

###### Characteristics of *mcr-1*-positive clinical Enterobacteriaceae isolates in Singapore

  **Isolate**           **Specimen**   **Species**       **Date of isolation**   **MLST**                           **β-lactamases**   ***ISApl1* associated**   ***mcr-1* transmissible via conjugation**[a](#t1-fn2){ref-type="fn"}   **MIC (mg/L)**[b](#t1-fn3){ref-type="fn"}                                                                               
  --------------------- -------------- ----------------- ----------------------- ---------------------------------- ------------------ ------------------------- ---------------------------------------------------------------------- ------------------------------------------- ------ ------- ------- ------ ----- ---- ----- ----- ------- ------- ------ -----
  NM12                  Urine          *E. coli*         11/01/2016              ST460[C](#t1-fn4){ref-type="fn"}   TEM-1              Yes                       Yes, ≈10^−6^                                                           4                                           4      ≤0.25   ≤0.25   ≤0.5   ≤4    ≤1   ≥32   64    2       4       \<1    \<2
  NM4                   Urine          *E. coli*         14/01/2016              ST156                              TEM-1              No                        Yes, ≈10^−7^                                                           4                                           4      ≤0.25   ≤0.25   ≤0.5   ≥64   16   ≥32   ≤4    1       2       \>16   \<2
  NM2                   Urine          *K. pneumoniae*   13/01/2016              ST1535                             TEM-1, CTX-M-15    No                        Yes, ≈10^−3^                                                           24                                          8      ≤0.25   ≤0.25   ≤0.5   ≤4    16   ≥32   ≤4    1       2       \<1    \<2
  Transconjugant NM12   ---            *E. coli*         ---                     ---                                TEM-1              ---                       ---                                                                    2                                           2      ≤0.25   ≤0.25   ≤0.5   ≤4    ≤1   ≥32   128   2       4       ≤1     ≤2
  Transconjugant NM4    ---            *E. coli*         ---                     ---                                TEM-1              ---                       ---                                                                    4                                           6      ≤0.25   ≤0.25   ≤0.5   ≤64   16   ≥32   ≤4    1       2       ≥16    ≤2
  Transconjugant NM2    ---            *E. coli*         ---                     ---                                Not detected       ---                       ---                                                                    8                                           6      ≤0.25   ≤0.25   ≤0.5   ≤4    ≤1   8     ≤4    ≤0.25   ≤0.12   ≤1     ≤2
  J53                   ---            *E. coli*         ---                     ---                                ---                ---                       ---                                                                    0.5                                         0.25   ≤0.25   ≤0.25   ≤0.5   ≤4    ≤1   8     ≤4    ≤0.25   ≤0.12   ≤1     ≤2

Abbreviations: amikacin, AMK; ampicillin, AMP; ceftazidime, CAZ; ciprofloxacin, CIP; colistin, COL; cefotaximase, CTX; ertapenem, ETP; cefoxitin, FOX; gentamicin, GEM; imipenem, IMP; levofloxacin, LEV; minimum inhibitory concentration, MIC; meropenem, MEM; polymyxin B, PB; piperacillin-tazobactam, PTZ.

The conjugation efficiency is calculated as the number of transconjugants per donor cell.

The interpretation of results of susceptibility testing were based on European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines. For colistin, a susceptible breakpoint of ≤2 mg/L and a resistant breakpoint of\>2 mg/L was applied. Because no interpretative criteria are available for polymyxin B, colistin breakpoints were applied.

The Institut Pasteur MLST scheme was utilized. The following new allelic profile was obtained: *dinB* 22; *pabB* 21; *putB* 23; *trpB* 127; *icdA* 61; *polB* 109; *trpA* 41; *uidA* 164, and was assigned as ST460.
